Once-daily liraglutide compared favorably with twice-daily exenatide, with similar improvements in A1C and body weight reductions
Newer research is looking at how the anti-inflammatory effects of these drugs might be helpful to people living with neurodegenerative diseases, such as Alzheimers and Parkinsons
GLP-1 Drugs Drop More Than Just Weight October 19, 2023 The S&P 500 Index (+13.9% year-to-date) and the Nasdaq Composite (+29.7% year-to-date) have performed well so far in 2023, fueled by optimism surrounding artificial intelligence (AI), declining inflation and the economys resilience in the face of rising interest rates
For overall safety considerations, see our peptide safety guide
We can now confidently say we have a drug that matches bariatric surgery outcomes
Struggling with stubborn weight, nonstop hunger, or blood sugar swings that make every diet fail by week two